Global Encapsulated iPSC-Derived Islet Cell Therapy Supply, Demand and Key Producers, 2026-2032
The global Encapsulated iPSC-Derived Islet Cell Therapy market size is expected to reach $ 572 million by 2032, rising at a market growth of 44.9% CAGR during the forecast period (2026-2032).
Encapsulated iPSC-Derived Islet Cell Therapy is a regenerative medicine approach in which human induced pluripotent stem cell (iPSC)-derived islet-like cells or ?-cell clusters are combined with immune-isolation devices, hydrogel microcapsules, bioprinted scaffolds, or localized immune-tolerance materials before implantation into the body. The therapy is designed to replace the damaged or absent pancreatic islet function in patients with type 1 diabetes and other insulin-dependent forms of diabetes. By sensing blood glucose levels and secreting insulin, glucagon, and other endocrine hormones, these therapies aim to restore physiological glucose regulation. Key product development priorities include cell maturation, endocrine cell purity, dosing strategy, glucose responsiveness, mass transfer performance of encapsulation materials, retrievability, immune protection efficacy, GMP batch consistency, and long-term safety. The overall gross margin is approximately 70%.
Demand for encapsulated iPSC-derived islet cell therapies is primarily driven by the unmet needs of patients with type 1 diabetes who require lifelong insulin therapy, face a high risk of severe hypoglycemia, have limited access to donor islets, and often require immunosuppressive treatment following transplantation. By combining a scalable iPSC-derived cell source with immune-protective encapsulation technologies, these therapies seek to achieve durable glycemic control without lifelong systemic immunosuppression. Their greatest clinical value lies in high-risk type 1 diabetes, brittle diabetes, and as a potential alternative to donor islet transplantation.
Competition is shifting from cell differentiation capability alone toward integrated expertise spanning cell biology, biomaterials, medical devices, and manufacturing processes. Macroencapsulation devices emphasize retrievability and clinical controllability, while hydrogel and microcapsule technologies focus on efficient nutrient and oxygen transport together with localized immune isolation. Bioprinted tissue constructs aim to recreate physiological cellular architecture, improve nutrient supply, and enhance long-term graft functionality after implantation. Key barriers throughout the supply chain include the establishment of clinical-grade iPSC banks, reproducible directed differentiation, biocompatible encapsulation materials, preservation of cell function under hypoxic conditions, and scalable GMP manufacturing systems.
Regional opportunities are primarily concentrated in the United States, Canada, Europe, and Israel, where regenerative medicine translation is advancing rapidly. In the near term, market activity is expected to remain focused on clinical trial supply, technology licensing, co-development partnerships, and manufacturing process validation. Commercial adoption will largely depend on the safety profile of first-generation products, C-peptide restoration, implant durability, device retrievability, and reimbursement acceptance. If encapsulation or immune-evasion strategies can substantially reduce or eliminate the need for immunosuppression, the eligible patient population and commercial potential of this therapeutic approach could expand significantly.
Report Scope
This report studies the global Encapsulated iPSC-Derived Islet Cell Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Encapsulated iPSC-Derived Islet Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Encapsulated iPSC-Derived Islet Cell Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Encapsulated iPSC-Derived Islet Cell Therapy total market, 2021-2032, (USD Million)
Global Encapsulated iPSC-Derived Islet Cell Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Encapsulated iPSC-Derived Islet Cell Therapy total market, key domestic companies, and share, (USD Million)
Global Encapsulated iPSC-Derived Islet Cell Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global Encapsulated iPSC-Derived Islet Cell Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global Encapsulated iPSC-Derived Islet Cell Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Encapsulated iPSC-Derived Islet Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vertex Pharmaceuticals, Aspect Biosystems, Sernova, Evotec, Sana Biotechnology, Kadimastem, iTolerance, Seraxis, CRISPR Therapeutics, Novo Nordisk, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Encapsulated iPSC-Derived Islet Cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Encapsulated iPSC-Derived Islet Cell Therapy Market, By Region:
1. How big is the global Encapsulated iPSC-Derived Islet Cell Therapy market?
2. What is the demand of the global Encapsulated iPSC-Derived Islet Cell Therapy market?
3. What is the year over year growth of the global Encapsulated iPSC-Derived Islet Cell Therapy market?
4. What is the total value of the global Encapsulated iPSC-Derived Islet Cell Therapy market?
5. Who are the Major Players in the global Encapsulated iPSC-Derived Islet Cell Therapy market?
6. What are the growth factors driving the market demand?
Encapsulated iPSC-Derived Islet Cell Therapy is a regenerative medicine approach in which human induced pluripotent stem cell (iPSC)-derived islet-like cells or ?-cell clusters are combined with immune-isolation devices, hydrogel microcapsules, bioprinted scaffolds, or localized immune-tolerance materials before implantation into the body. The therapy is designed to replace the damaged or absent pancreatic islet function in patients with type 1 diabetes and other insulin-dependent forms of diabetes. By sensing blood glucose levels and secreting insulin, glucagon, and other endocrine hormones, these therapies aim to restore physiological glucose regulation. Key product development priorities include cell maturation, endocrine cell purity, dosing strategy, glucose responsiveness, mass transfer performance of encapsulation materials, retrievability, immune protection efficacy, GMP batch consistency, and long-term safety. The overall gross margin is approximately 70%.
Demand for encapsulated iPSC-derived islet cell therapies is primarily driven by the unmet needs of patients with type 1 diabetes who require lifelong insulin therapy, face a high risk of severe hypoglycemia, have limited access to donor islets, and often require immunosuppressive treatment following transplantation. By combining a scalable iPSC-derived cell source with immune-protective encapsulation technologies, these therapies seek to achieve durable glycemic control without lifelong systemic immunosuppression. Their greatest clinical value lies in high-risk type 1 diabetes, brittle diabetes, and as a potential alternative to donor islet transplantation.
Competition is shifting from cell differentiation capability alone toward integrated expertise spanning cell biology, biomaterials, medical devices, and manufacturing processes. Macroencapsulation devices emphasize retrievability and clinical controllability, while hydrogel and microcapsule technologies focus on efficient nutrient and oxygen transport together with localized immune isolation. Bioprinted tissue constructs aim to recreate physiological cellular architecture, improve nutrient supply, and enhance long-term graft functionality after implantation. Key barriers throughout the supply chain include the establishment of clinical-grade iPSC banks, reproducible directed differentiation, biocompatible encapsulation materials, preservation of cell function under hypoxic conditions, and scalable GMP manufacturing systems.
Regional opportunities are primarily concentrated in the United States, Canada, Europe, and Israel, where regenerative medicine translation is advancing rapidly. In the near term, market activity is expected to remain focused on clinical trial supply, technology licensing, co-development partnerships, and manufacturing process validation. Commercial adoption will largely depend on the safety profile of first-generation products, C-peptide restoration, implant durability, device retrievability, and reimbursement acceptance. If encapsulation or immune-evasion strategies can substantially reduce or eliminate the need for immunosuppression, the eligible patient population and commercial potential of this therapeutic approach could expand significantly.
Report Scope
This report studies the global Encapsulated iPSC-Derived Islet Cell Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Encapsulated iPSC-Derived Islet Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Encapsulated iPSC-Derived Islet Cell Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Encapsulated iPSC-Derived Islet Cell Therapy total market, 2021-2032, (USD Million)
Global Encapsulated iPSC-Derived Islet Cell Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Encapsulated iPSC-Derived Islet Cell Therapy total market, key domestic companies, and share, (USD Million)
Global Encapsulated iPSC-Derived Islet Cell Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global Encapsulated iPSC-Derived Islet Cell Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global Encapsulated iPSC-Derived Islet Cell Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Encapsulated iPSC-Derived Islet Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vertex Pharmaceuticals, Aspect Biosystems, Sernova, Evotec, Sana Biotechnology, Kadimastem, iTolerance, Seraxis, CRISPR Therapeutics, Novo Nordisk, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Encapsulated iPSC-Derived Islet Cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Encapsulated iPSC-Derived Islet Cell Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Macroencapsulation Device Therapy
- Hydrogel Microencapsulation Therapy
- Conformal Coating Encapsulation Therapy
- Bioprinted Encapsulated Tissue Therapy
- Local Immune Tolerance Matrix Therapy
- Other Encapsulation Architectures
- Pancreatic Endoderm Cells
- Immature Endocrine Progenitors
- Beta Cell-Enriched Clusters
- Islet-Like Endocrine Clusters
- Mature Multihormonal Islet Cells
- Other Maturity Stages
- Physical Immune Isolation
- Local Immune Tolerance
- Hypoimmune Gene Editing
- Encapsulation Plus Gene Editing
- Systemic Immunosuppression-Enabled
- Other Immune Strategies
- Discovery Research
- Preclinical Development
- IND-Enabling Development
- Phase 1/2 Clinical Stage
- Pivotal and Registration Stage
- Discontinued or Legacy Assets
- Type 1 Diabetes
- Brittle Diabetes
- Insulin-Dependent Type 2 Diabetes
- Post-Pancreatectomy Diabetes
- Islet Replacement Research
- Other Diabetes Indications
- Vertex Pharmaceuticals
- Aspect Biosystems
- Sernova
- Evotec
- Sana Biotechnology
- Kadimastem
- iTolerance
- Seraxis
- CRISPR Therapeutics
- Novo Nordisk
- Eli Lilly
- Sigilon Therapeutics
1. How big is the global Encapsulated iPSC-Derived Islet Cell Therapy market?
2. What is the demand of the global Encapsulated iPSC-Derived Islet Cell Therapy market?
3. What is the year over year growth of the global Encapsulated iPSC-Derived Islet Cell Therapy market?
4. What is the total value of the global Encapsulated iPSC-Derived Islet Cell Therapy market?
5. Who are the Major Players in the global Encapsulated iPSC-Derived Islet Cell Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Encapsulated iPSC-Derived Islet Cell Therapy Introduction
1.2 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Encapsulated iPSC-Derived Islet Cell Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.3 China Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.4 Europe Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.5 Japan Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.8 India Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.2 World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region
2.2.1 World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2026)
2.2.2 World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.4 China Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.5 Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.6 Japan Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.7 South Korea Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.8 ASEAN Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.9 India Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
3 WORLD ENCAPSULATED IPSC-DERIVED ISLET CELL THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Encapsulated iPSC-Derived Islet Cell Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for Encapsulated iPSC-Derived Islet Cell Therapy in 2025
3.3 Encapsulated iPSC-Derived Islet Cell Therapy Company Evaluation Quadrant
3.4 Encapsulated iPSC-Derived Islet Cell Therapy Market: Overall Company Footprint Analysis
3.4.1 Encapsulated iPSC-Derived Islet Cell Therapy Market: Region Footprint
3.4.2 Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Type Footprint
3.4.3 Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Comparison
4.2.1 United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Encapsulated iPSC-Derived Islet Cell Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based Encapsulated iPSC-Derived Islet Cell Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue, (2021-2026)
4.4 China Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based Encapsulated iPSC-Derived Islet Cell Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue, (2021-2026)
4.5 Rest of World Based Encapsulated iPSC-Derived Islet Cell Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Encapsulated iPSC-Derived Islet Cell Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Macroencapsulation Device Therapy
5.2.2 Hydrogel Microencapsulation Therapy
5.2.3 Conformal Coating Encapsulation Therapy
5.2.4 Bioprinted Encapsulated Tissue Therapy
5.2.5 Local Immune Tolerance Matrix Therapy
5.2.6 Other Encapsulation Architectures
5.3 Market Segment by Type
5.3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
5.3.2 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2027-2032)
5.3.3 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CELL MATURITY STAGE
6.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Overview by Cell Maturity Stage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cell Maturity Stage
6.2.1 Pancreatic Endoderm Cells
6.2.2 Immature Endocrine Progenitors
6.2.3 Beta Cell-Enriched Clusters
6.2.4 Islet-Like Endocrine Clusters
6.2.5 Mature Multihormonal Islet Cells
6.2.6 Other Maturity Stages
6.3 Market Segment by Cell Maturity Stage
6.3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage (2021-2026)
6.3.2 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage (2027-2032)
6.3.3 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Maturity Stage (2027-2032)
7 MARKET ANALYSIS BY IMMUNE PROTECTION STRATEGY
7.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Overview by Immune Protection Strategy: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Immune Protection Strategy
7.2.1 Physical Immune Isolation
7.2.2 Local Immune Tolerance
7.2.3 Hypoimmune Gene Editing
7.2.4 Encapsulation Plus Gene Editing
7.2.5 Systemic Immunosuppression-Enabled
7.2.6 Other Immune Strategies
7.3 Market Segment by Immune Protection Strategy
7.3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2021-2026)
7.3.2 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2027-2032)
7.3.3 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2027-2032)
8 MARKET ANALYSIS BY DEVELOPMENT STAGE
8.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Overview by Development Stage: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Development Stage
8.2.1 Discovery Research
8.2.2 Preclinical Development
8.2.3 IND-Enabling Development
8.2.4 Phase 1/2 Clinical Stage
8.2.5 Pivotal and Registration Stage
8.2.6 Discontinued or Legacy Assets
8.3 Market Segment by Development Stage
8.3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage (2021-2026)
8.3.2 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage (2027-2032)
8.3.3 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Development Stage (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Type 1 Diabetes
9.2.2 Brittle Diabetes
9.2.3 Insulin-Dependent Type 2 Diabetes
9.2.4 Post-Pancreatectomy Diabetes
9.2.5 Islet Replacement Research
9.2.6 Other Diabetes Indications
9.3 Market Segment by Application
9.3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
9.3.2 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2027-2032)
9.3.3 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 Vertex Pharmaceuticals
10.1.1 Vertex Pharmaceuticals Details
10.1.2 Vertex Pharmaceuticals Major Business
10.1.3 Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.1.4 Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 Vertex Pharmaceuticals Recent Developments/Updates
10.1.6 Vertex Pharmaceuticals Competitive Strengths & Weaknesses
10.2 Aspect Biosystems
10.2.1 Aspect Biosystems Details
10.2.2 Aspect Biosystems Major Business
10.2.3 Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.2.4 Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Aspect Biosystems Recent Developments/Updates
10.2.6 Aspect Biosystems Competitive Strengths & Weaknesses
10.3 Sernova
10.3.1 Sernova Details
10.3.2 Sernova Major Business
10.3.3 Sernova Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.3.4 Sernova Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Sernova Recent Developments/Updates
10.3.6 Sernova Competitive Strengths & Weaknesses
10.4 Evotec
10.4.1 Evotec Details
10.4.2 Evotec Major Business
10.4.3 Evotec Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.4.4 Evotec Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Evotec Recent Developments/Updates
10.4.6 Evotec Competitive Strengths & Weaknesses
10.5 Sana Biotechnology
10.5.1 Sana Biotechnology Details
10.5.2 Sana Biotechnology Major Business
10.5.3 Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.5.4 Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Sana Biotechnology Recent Developments/Updates
10.5.6 Sana Biotechnology Competitive Strengths & Weaknesses
10.6 Kadimastem
10.6.1 Kadimastem Details
10.6.2 Kadimastem Major Business
10.6.3 Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.6.4 Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 Kadimastem Recent Developments/Updates
10.6.6 Kadimastem Competitive Strengths & Weaknesses
10.7 iTolerance
10.7.1 iTolerance Details
10.7.2 iTolerance Major Business
10.7.3 iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.7.4 iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 iTolerance Recent Developments/Updates
10.7.6 iTolerance Competitive Strengths & Weaknesses
10.8 Seraxis
10.8.1 Seraxis Details
10.8.2 Seraxis Major Business
10.8.3 Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.8.4 Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Seraxis Recent Developments/Updates
10.8.6 Seraxis Competitive Strengths & Weaknesses
10.9 CRISPR Therapeutics
10.9.1 CRISPR Therapeutics Details
10.9.2 CRISPR Therapeutics Major Business
10.9.3 CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.9.4 CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 CRISPR Therapeutics Recent Developments/Updates
10.9.6 CRISPR Therapeutics Competitive Strengths & Weaknesses
10.10 Novo Nordisk
10.10.1 Novo Nordisk Details
10.10.2 Novo Nordisk Major Business
10.10.3 Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.10.4 Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 Novo Nordisk Recent Developments/Updates
10.10.6 Novo Nordisk Competitive Strengths & Weaknesses
10.11 Eli Lilly
10.11.1 Eli Lilly Details
10.11.2 Eli Lilly Major Business
10.11.3 Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.11.4 Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.11.5 Eli Lilly Recent Developments/Updates
10.11.6 Eli Lilly Competitive Strengths & Weaknesses
10.12 Sigilon Therapeutics
10.12.1 Sigilon Therapeutics Details
10.12.2 Sigilon Therapeutics Major Business
10.12.3 Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.12.4 Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.12.5 Sigilon Therapeutics Recent Developments/Updates
10.12.6 Sigilon Therapeutics Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Encapsulated iPSC-Derived Islet Cell Therapy Industry Chain
11.2 Encapsulated iPSC-Derived Islet Cell Therapy Upstream Analysis
11.3 Encapsulated iPSC-Derived Islet Cell Therapy Midstream Analysis
11.4 Encapsulated iPSC-Derived Islet Cell Therapy Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Encapsulated iPSC-Derived Islet Cell Therapy Introduction
1.2 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Encapsulated iPSC-Derived Islet Cell Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.3 China Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.4 Europe Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.5 Japan Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.3.8 India Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.2 World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region
2.2.1 World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2026)
2.2.2 World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.4 China Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.5 Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.6 Japan Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.7 South Korea Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.8 ASEAN Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
2.9 India Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032)
3 WORLD ENCAPSULATED IPSC-DERIVED ISLET CELL THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Encapsulated iPSC-Derived Islet Cell Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for Encapsulated iPSC-Derived Islet Cell Therapy in 2025
3.3 Encapsulated iPSC-Derived Islet Cell Therapy Company Evaluation Quadrant
3.4 Encapsulated iPSC-Derived Islet Cell Therapy Market: Overall Company Footprint Analysis
3.4.1 Encapsulated iPSC-Derived Islet Cell Therapy Market: Region Footprint
3.4.2 Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Type Footprint
3.4.3 Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Comparison
4.2.1 United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Encapsulated iPSC-Derived Islet Cell Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based Encapsulated iPSC-Derived Islet Cell Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue, (2021-2026)
4.4 China Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based Encapsulated iPSC-Derived Islet Cell Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue, (2021-2026)
4.5 Rest of World Based Encapsulated iPSC-Derived Islet Cell Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Encapsulated iPSC-Derived Islet Cell Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Macroencapsulation Device Therapy
5.2.2 Hydrogel Microencapsulation Therapy
5.2.3 Conformal Coating Encapsulation Therapy
5.2.4 Bioprinted Encapsulated Tissue Therapy
5.2.5 Local Immune Tolerance Matrix Therapy
5.2.6 Other Encapsulation Architectures
5.3 Market Segment by Type
5.3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
5.3.2 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2027-2032)
5.3.3 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CELL MATURITY STAGE
6.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Overview by Cell Maturity Stage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cell Maturity Stage
6.2.1 Pancreatic Endoderm Cells
6.2.2 Immature Endocrine Progenitors
6.2.3 Beta Cell-Enriched Clusters
6.2.4 Islet-Like Endocrine Clusters
6.2.5 Mature Multihormonal Islet Cells
6.2.6 Other Maturity Stages
6.3 Market Segment by Cell Maturity Stage
6.3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage (2021-2026)
6.3.2 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage (2027-2032)
6.3.3 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Maturity Stage (2027-2032)
7 MARKET ANALYSIS BY IMMUNE PROTECTION STRATEGY
7.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Overview by Immune Protection Strategy: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Immune Protection Strategy
7.2.1 Physical Immune Isolation
7.2.2 Local Immune Tolerance
7.2.3 Hypoimmune Gene Editing
7.2.4 Encapsulation Plus Gene Editing
7.2.5 Systemic Immunosuppression-Enabled
7.2.6 Other Immune Strategies
7.3 Market Segment by Immune Protection Strategy
7.3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2021-2026)
7.3.2 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2027-2032)
7.3.3 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2027-2032)
8 MARKET ANALYSIS BY DEVELOPMENT STAGE
8.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Overview by Development Stage: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Development Stage
8.2.1 Discovery Research
8.2.2 Preclinical Development
8.2.3 IND-Enabling Development
8.2.4 Phase 1/2 Clinical Stage
8.2.5 Pivotal and Registration Stage
8.2.6 Discontinued or Legacy Assets
8.3 Market Segment by Development Stage
8.3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage (2021-2026)
8.3.2 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage (2027-2032)
8.3.3 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Development Stage (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Type 1 Diabetes
9.2.2 Brittle Diabetes
9.2.3 Insulin-Dependent Type 2 Diabetes
9.2.4 Post-Pancreatectomy Diabetes
9.2.5 Islet Replacement Research
9.2.6 Other Diabetes Indications
9.3 Market Segment by Application
9.3.1 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
9.3.2 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2027-2032)
9.3.3 World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 Vertex Pharmaceuticals
10.1.1 Vertex Pharmaceuticals Details
10.1.2 Vertex Pharmaceuticals Major Business
10.1.3 Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.1.4 Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 Vertex Pharmaceuticals Recent Developments/Updates
10.1.6 Vertex Pharmaceuticals Competitive Strengths & Weaknesses
10.2 Aspect Biosystems
10.2.1 Aspect Biosystems Details
10.2.2 Aspect Biosystems Major Business
10.2.3 Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.2.4 Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Aspect Biosystems Recent Developments/Updates
10.2.6 Aspect Biosystems Competitive Strengths & Weaknesses
10.3 Sernova
10.3.1 Sernova Details
10.3.2 Sernova Major Business
10.3.3 Sernova Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.3.4 Sernova Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Sernova Recent Developments/Updates
10.3.6 Sernova Competitive Strengths & Weaknesses
10.4 Evotec
10.4.1 Evotec Details
10.4.2 Evotec Major Business
10.4.3 Evotec Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.4.4 Evotec Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Evotec Recent Developments/Updates
10.4.6 Evotec Competitive Strengths & Weaknesses
10.5 Sana Biotechnology
10.5.1 Sana Biotechnology Details
10.5.2 Sana Biotechnology Major Business
10.5.3 Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.5.4 Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Sana Biotechnology Recent Developments/Updates
10.5.6 Sana Biotechnology Competitive Strengths & Weaknesses
10.6 Kadimastem
10.6.1 Kadimastem Details
10.6.2 Kadimastem Major Business
10.6.3 Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.6.4 Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 Kadimastem Recent Developments/Updates
10.6.6 Kadimastem Competitive Strengths & Weaknesses
10.7 iTolerance
10.7.1 iTolerance Details
10.7.2 iTolerance Major Business
10.7.3 iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.7.4 iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 iTolerance Recent Developments/Updates
10.7.6 iTolerance Competitive Strengths & Weaknesses
10.8 Seraxis
10.8.1 Seraxis Details
10.8.2 Seraxis Major Business
10.8.3 Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.8.4 Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Seraxis Recent Developments/Updates
10.8.6 Seraxis Competitive Strengths & Weaknesses
10.9 CRISPR Therapeutics
10.9.1 CRISPR Therapeutics Details
10.9.2 CRISPR Therapeutics Major Business
10.9.3 CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.9.4 CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 CRISPR Therapeutics Recent Developments/Updates
10.9.6 CRISPR Therapeutics Competitive Strengths & Weaknesses
10.10 Novo Nordisk
10.10.1 Novo Nordisk Details
10.10.2 Novo Nordisk Major Business
10.10.3 Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.10.4 Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 Novo Nordisk Recent Developments/Updates
10.10.6 Novo Nordisk Competitive Strengths & Weaknesses
10.11 Eli Lilly
10.11.1 Eli Lilly Details
10.11.2 Eli Lilly Major Business
10.11.3 Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.11.4 Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.11.5 Eli Lilly Recent Developments/Updates
10.11.6 Eli Lilly Competitive Strengths & Weaknesses
10.12 Sigilon Therapeutics
10.12.1 Sigilon Therapeutics Details
10.12.2 Sigilon Therapeutics Major Business
10.12.3 Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
10.12.4 Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
10.12.5 Sigilon Therapeutics Recent Developments/Updates
10.12.6 Sigilon Therapeutics Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Encapsulated iPSC-Derived Islet Cell Therapy Industry Chain
11.2 Encapsulated iPSC-Derived Islet Cell Therapy Upstream Analysis
11.3 Encapsulated iPSC-Derived Islet Cell Therapy Midstream Analysis
11.4 Encapsulated iPSC-Derived Islet Cell Therapy Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Encapsulated iPSC-Derived Islet Cell Therapy Players in 2025
Table 12. World Encapsulated iPSC-Derived Islet Cell Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Encapsulated iPSC-Derived Islet Cell Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Encapsulated iPSC-Derived Islet Cell Therapy Players
Table 15. Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Type Footprint
Table 16. Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Application Footprint
Table 17. Encapsulated iPSC-Derived Islet Cell Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Encapsulated iPSC-Derived Islet Cell Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Encapsulated iPSC-Derived Islet Cell Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share (2021-2026)
Table 23. China Based Encapsulated iPSC-Derived Islet Cell Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based Encapsulated iPSC-Derived Islet Cell Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share (2021-2026)
Table 29. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Value by Cell Maturity Stage (2021-2026) & (USD Million)
Table 34. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage (2027-2032) & (USD Million)
Table 35. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy, (USD Million), 2021 & 2025 & 2032
Table 36. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Value by Immune Protection Strategy (2021-2026) & (USD Million)
Table 37. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2027-2032) & (USD Million)
Table 38. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Table 39. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Value by Development Stage (2021-2026) & (USD Million)
Table 40. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage (2027-2032) & (USD Million)
Table 41. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & (USD Million)
Table 43. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2027-2032) & (USD Million)
Table 44. Vertex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 45. Vertex Pharmaceuticals Major Business
Table 46. Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 47. Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Vertex Pharmaceuticals Recent Developments/Updates
Table 49. Vertex Pharmaceuticals Competitive Strengths & Weaknesses
Table 50. Aspect Biosystems Basic Information, Manufacturing Base and Competitors
Table 51. Aspect Biosystems Major Business
Table 52. Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 53. Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Aspect Biosystems Recent Developments/Updates
Table 55. Aspect Biosystems Competitive Strengths & Weaknesses
Table 56. Sernova Basic Information, Manufacturing Base and Competitors
Table 57. Sernova Major Business
Table 58. Sernova Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 59. Sernova Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Sernova Recent Developments/Updates
Table 61. Sernova Competitive Strengths & Weaknesses
Table 62. Evotec Basic Information, Manufacturing Base and Competitors
Table 63. Evotec Major Business
Table 64. Evotec Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 65. Evotec Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Evotec Recent Developments/Updates
Table 67. Evotec Competitive Strengths & Weaknesses
Table 68. Sana Biotechnology Basic Information, Manufacturing Base and Competitors
Table 69. Sana Biotechnology Major Business
Table 70. Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 71. Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Sana Biotechnology Recent Developments/Updates
Table 73. Sana Biotechnology Competitive Strengths & Weaknesses
Table 74. Kadimastem Basic Information, Manufacturing Base and Competitors
Table 75. Kadimastem Major Business
Table 76. Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 77. Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Kadimastem Recent Developments/Updates
Table 79. Kadimastem Competitive Strengths & Weaknesses
Table 80. iTolerance Basic Information, Manufacturing Base and Competitors
Table 81. iTolerance Major Business
Table 82. iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 83. iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. iTolerance Recent Developments/Updates
Table 85. iTolerance Competitive Strengths & Weaknesses
Table 86. Seraxis Basic Information, Manufacturing Base and Competitors
Table 87. Seraxis Major Business
Table 88. Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 89. Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Seraxis Recent Developments/Updates
Table 91. Seraxis Competitive Strengths & Weaknesses
Table 92. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 93. CRISPR Therapeutics Major Business
Table 94. CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 95. CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. CRISPR Therapeutics Recent Developments/Updates
Table 97. CRISPR Therapeutics Competitive Strengths & Weaknesses
Table 98. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 99. Novo Nordisk Major Business
Table 100. Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 101. Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Novo Nordisk Recent Developments/Updates
Table 103. Novo Nordisk Competitive Strengths & Weaknesses
Table 104. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 105. Eli Lilly Major Business
Table 106. Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 107. Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Eli Lilly Recent Developments/Updates
Table 109. Eli Lilly Competitive Strengths & Weaknesses
Table 110. Sigilon Therapeutics Basic Information, Manufacturing Base and Competitors
Table 111. Sigilon Therapeutics Major Business
Table 112. Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 113. Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Sigilon Therapeutics Recent Developments/Updates
Table 115. Sigilon Therapeutics Competitive Strengths & Weaknesses
Table 116. Global Key Players of Encapsulated iPSC-Derived Islet Cell Therapy Upstream (Raw Materials)
Table 117. Global Encapsulated iPSC-Derived Islet Cell Therapy Typical Customers
Table 1. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Encapsulated iPSC-Derived Islet Cell Therapy Players in 2025
Table 12. World Encapsulated iPSC-Derived Islet Cell Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Encapsulated iPSC-Derived Islet Cell Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Encapsulated iPSC-Derived Islet Cell Therapy Players
Table 15. Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Type Footprint
Table 16. Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Application Footprint
Table 17. Encapsulated iPSC-Derived Islet Cell Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Encapsulated iPSC-Derived Islet Cell Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Encapsulated iPSC-Derived Islet Cell Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share (2021-2026)
Table 23. China Based Encapsulated iPSC-Derived Islet Cell Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based Encapsulated iPSC-Derived Islet Cell Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share (2021-2026)
Table 29. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Value by Cell Maturity Stage (2021-2026) & (USD Million)
Table 34. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage (2027-2032) & (USD Million)
Table 35. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy, (USD Million), 2021 & 2025 & 2032
Table 36. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Value by Immune Protection Strategy (2021-2026) & (USD Million)
Table 37. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2027-2032) & (USD Million)
Table 38. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Table 39. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Value by Development Stage (2021-2026) & (USD Million)
Table 40. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage (2027-2032) & (USD Million)
Table 41. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & (USD Million)
Table 43. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2027-2032) & (USD Million)
Table 44. Vertex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 45. Vertex Pharmaceuticals Major Business
Table 46. Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 47. Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Vertex Pharmaceuticals Recent Developments/Updates
Table 49. Vertex Pharmaceuticals Competitive Strengths & Weaknesses
Table 50. Aspect Biosystems Basic Information, Manufacturing Base and Competitors
Table 51. Aspect Biosystems Major Business
Table 52. Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 53. Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Aspect Biosystems Recent Developments/Updates
Table 55. Aspect Biosystems Competitive Strengths & Weaknesses
Table 56. Sernova Basic Information, Manufacturing Base and Competitors
Table 57. Sernova Major Business
Table 58. Sernova Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 59. Sernova Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Sernova Recent Developments/Updates
Table 61. Sernova Competitive Strengths & Weaknesses
Table 62. Evotec Basic Information, Manufacturing Base and Competitors
Table 63. Evotec Major Business
Table 64. Evotec Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 65. Evotec Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Evotec Recent Developments/Updates
Table 67. Evotec Competitive Strengths & Weaknesses
Table 68. Sana Biotechnology Basic Information, Manufacturing Base and Competitors
Table 69. Sana Biotechnology Major Business
Table 70. Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 71. Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Sana Biotechnology Recent Developments/Updates
Table 73. Sana Biotechnology Competitive Strengths & Weaknesses
Table 74. Kadimastem Basic Information, Manufacturing Base and Competitors
Table 75. Kadimastem Major Business
Table 76. Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 77. Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Kadimastem Recent Developments/Updates
Table 79. Kadimastem Competitive Strengths & Weaknesses
Table 80. iTolerance Basic Information, Manufacturing Base and Competitors
Table 81. iTolerance Major Business
Table 82. iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 83. iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. iTolerance Recent Developments/Updates
Table 85. iTolerance Competitive Strengths & Weaknesses
Table 86. Seraxis Basic Information, Manufacturing Base and Competitors
Table 87. Seraxis Major Business
Table 88. Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 89. Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Seraxis Recent Developments/Updates
Table 91. Seraxis Competitive Strengths & Weaknesses
Table 92. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 93. CRISPR Therapeutics Major Business
Table 94. CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 95. CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. CRISPR Therapeutics Recent Developments/Updates
Table 97. CRISPR Therapeutics Competitive Strengths & Weaknesses
Table 98. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 99. Novo Nordisk Major Business
Table 100. Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 101. Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Novo Nordisk Recent Developments/Updates
Table 103. Novo Nordisk Competitive Strengths & Weaknesses
Table 104. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 105. Eli Lilly Major Business
Table 106. Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 107. Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Eli Lilly Recent Developments/Updates
Table 109. Eli Lilly Competitive Strengths & Weaknesses
Table 110. Sigilon Therapeutics Basic Information, Manufacturing Base and Competitors
Table 111. Sigilon Therapeutics Major Business
Table 112. Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Services
Table 113. Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Sigilon Therapeutics Recent Developments/Updates
Table 115. Sigilon Therapeutics Competitive Strengths & Weaknesses
Table 116. Global Key Players of Encapsulated iPSC-Derived Islet Cell Therapy Upstream (Raw Materials)
Table 117. Global Encapsulated iPSC-Derived Islet Cell Therapy Typical Customers
LIST OF FIGURES
Figure 1. Encapsulated iPSC-Derived Islet Cell Therapy Picture
Figure 2. World Encapsulated iPSC-Derived Islet Cell Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Encapsulated iPSC-Derived Islet Cell Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 13. Encapsulated iPSC-Derived Islet Cell Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Encapsulated iPSC-Derived Islet Cell Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Encapsulated iPSC-Derived Islet Cell Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Encapsulated iPSC-Derived Islet Cell Therapy Markets in 2025
Figure 27. United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type in 2025
Figure 31. Macroencapsulation Device Therapy
Figure 32. Hydrogel Microencapsulation Therapy
Figure 33. Conformal Coating Encapsulation Therapy
Figure 34. Bioprinted Encapsulated Tissue Therapy
Figure 35. Local Immune Tolerance Matrix Therapy
Figure 36. Other Encapsulation Architectures
Figure 37. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2032)
Figure 38. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage, (USD Million), 2021 & 2025 & 2032
Figure 39. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Maturity Stage in 2025
Figure 40. Pancreatic Endoderm Cells
Figure 41. Immature Endocrine Progenitors
Figure 42. Beta Cell-Enriched Clusters
Figure 43. Islet-Like Endocrine Clusters
Figure 44. Mature Multihormonal Islet Cells
Figure 45. Other Maturity Stages
Figure 46. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Maturity Stage (2021-2032)
Figure 47. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy, (USD Million), 2021 & 2025 & 2032
Figure 48. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy in 2025
Figure 49. Physical Immune Isolation
Figure 50. Local Immune Tolerance
Figure 51. Hypoimmune Gene Editing
Figure 52. Encapsulation Plus Gene Editing
Figure 53. Systemic Immunosuppression-Enabled
Figure 54. Other Immune Strategies
Figure 55. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2021-2032)
Figure 56. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Figure 57. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Development Stage in 2025
Figure 58. Discovery Research
Figure 59. Preclinical Development
Figure 60. IND-Enabling Development
Figure 61. Phase 1/2 Clinical Stage
Figure 62. Pivotal and Registration Stage
Figure 63. Discontinued or Legacy Assets
Figure 64. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Development Stage (2021-2032)
Figure 65. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 66. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application in 2025
Figure 67. Type 1 Diabetes
Figure 68. Brittle Diabetes
Figure 69. Insulin-Dependent Type 2 Diabetes
Figure 70. Post-Pancreatectomy Diabetes
Figure 71. Islet Replacement Research
Figure 72. Other Diabetes Indications
Figure 73. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2032)
Figure 74. Encapsulated iPSC-Derived Islet Cell Therapy Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Encapsulated iPSC-Derived Islet Cell Therapy Picture
Figure 2. World Encapsulated iPSC-Derived Islet Cell Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Encapsulated iPSC-Derived Islet Cell Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Encapsulated iPSC-Derived Islet Cell Therapy Revenue (2021-2032) & (USD Million)
Figure 13. Encapsulated iPSC-Derived Islet Cell Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Encapsulated iPSC-Derived Islet Cell Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Encapsulated iPSC-Derived Islet Cell Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Encapsulated iPSC-Derived Islet Cell Therapy Markets in 2025
Figure 27. United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type in 2025
Figure 31. Macroencapsulation Device Therapy
Figure 32. Hydrogel Microencapsulation Therapy
Figure 33. Conformal Coating Encapsulation Therapy
Figure 34. Bioprinted Encapsulated Tissue Therapy
Figure 35. Local Immune Tolerance Matrix Therapy
Figure 36. Other Encapsulation Architectures
Figure 37. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2032)
Figure 38. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage, (USD Million), 2021 & 2025 & 2032
Figure 39. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Maturity Stage in 2025
Figure 40. Pancreatic Endoderm Cells
Figure 41. Immature Endocrine Progenitors
Figure 42. Beta Cell-Enriched Clusters
Figure 43. Islet-Like Endocrine Clusters
Figure 44. Mature Multihormonal Islet Cells
Figure 45. Other Maturity Stages
Figure 46. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Maturity Stage (2021-2032)
Figure 47. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy, (USD Million), 2021 & 2025 & 2032
Figure 48. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy in 2025
Figure 49. Physical Immune Isolation
Figure 50. Local Immune Tolerance
Figure 51. Hypoimmune Gene Editing
Figure 52. Encapsulation Plus Gene Editing
Figure 53. Systemic Immunosuppression-Enabled
Figure 54. Other Immune Strategies
Figure 55. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2021-2032)
Figure 56. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Figure 57. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Development Stage in 2025
Figure 58. Discovery Research
Figure 59. Preclinical Development
Figure 60. IND-Enabling Development
Figure 61. Phase 1/2 Clinical Stage
Figure 62. Pivotal and Registration Stage
Figure 63. Discontinued or Legacy Assets
Figure 64. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Development Stage (2021-2032)
Figure 65. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 66. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application in 2025
Figure 67. Type 1 Diabetes
Figure 68. Brittle Diabetes
Figure 69. Insulin-Dependent Type 2 Diabetes
Figure 70. Post-Pancreatectomy Diabetes
Figure 71. Islet Replacement Research
Figure 72. Other Diabetes Indications
Figure 73. World Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2032)
Figure 74. Encapsulated iPSC-Derived Islet Cell Therapy Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
